Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

Lymphoid 2Thoracic 1Sarcoma 1Gynecologic 1

Conditions

Sarcoma 1339Glioblastoma 493Gliosarcoma 470Osteosarcoma 363Brain Neoplasms 321Central Nervous System Neoplasms 276Astrocytoma 262Dendritic Cell Sarcoma, Interdigitating 258Gastrointestinal Stromal Tumors 252Neoplasms 231Glioma 229Lymphoma 226Neuroblastoma 209Rhabdomyosarcoma 208Breast Neoplasms 205Sarcoma, Ewing 202Recurrence 202Burkitt Lymphoma 198Lymphoma, Non-Hodgkin 196Precursor Cell Lymphoblastic Leukemia-Lymphoma 195Oligodendroglioma 192Melanoma 182Ovarian Neoplasms 177Lymphoma, Large B-Cell, Diffuse 173Neoplasm Metastasis 172Bone Neoplasms 169Lymphoma, Follicular 158Liposarcoma 144Leukemia, Lymphocytic, Chronic, B-Cell 144Lymphoma, Mantle-Cell 143

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × HIV Seropositivity × Sarcoma × Clear all
NCT02029430 2024-06-11

A Study to Investigate ALDOXORUBICIN in HIV-infected Subjects With Kaposi's Sarcoma

ImmunityBio, Inc.

Phase 2 Completed
15 enrolled 9 charts
Sarcoma

Acquired Immunodeficiency Syndrome, HIV Seropositivity, Neoplasms, Sarcoma, Sarcoma, Kaposi

Data powered by HemOnc (CC BY 4.0) Colophon âš¡